Nalfurafine

DB13471InvestigationalSmall molecule

Nalfurafine: Overview.

Mechanism: Pharmacologically active on Kappa-type opioid receptor
Curator reviewed
Formula / weight: C₂₈H₃₂N₂O₅ · 476.573 g/mol (avg)
Code names: MT-9938

Resolves to

Compound

Clinical / RWD

Structure

InChIKeyXGZZHZMWIXFATA-UEZBDDGYSA-NSMILESCN([C@@H]1CC[C@@]2(O)[C@H]3CC4=CC=C(O)C5=C4[C@@]2(CCN3CC2CC2)[C@H]1O5)C(=O)\C=C\C1=COC=C1

Targets

What you can answer from here — as of September 13, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

11Clinical trialsPhase, status and sponsor resolved per trial

1Marketed productAcross 1 country and 1 labeller

1ATC codeIncluding every combination product, plus 5 drug categories

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Nalfurafine, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.